Empliciti (Elotuzumab): First SLAMF7 Antibody Therapy Approved for the Treatment of Patients with Previously Treated Multiple Myeloma.
Lisa A
LA
Raedler
Clin Cancer Res. 2013 Jul 1;19(13):3337-44
23515406
Oncologist. 2013;18(1):27-36
23299777
BMJ Open. 2015 Nov 27;5(11):e009576
26614625
N Engl J Med. 2015 Aug 13;373(7):621-31
26035255
Oncologist. 2013;18(1):37-45
23299776
Blood. 2008 Mar 1;111(5):2516-20
17975015
Br J Biomed Sci. 2013;70(3):110-20
24273897